Welcome to LookChem.com Sign In|Join Free
  • or
Daturabietatriene, a bicyclic terpenoid compound, is a type of tropine alkaloid found in the toxic plant Datura stramonium, commonly known as jimsonweed. It is responsible for the hallucinogenic and toxic effects of the plant, acting as a competitive antagonist at muscarinic acetylcholine receptors in the central and peripheral nervous system, causing symptoms such as blurred vision, dilated pupils, dry mouth, and confusion. Due to its severe toxicity and potential for fatal outcomes, Datura stramonium should be handled with caution and avoided for consumption.

65894-41-9

Post Buying Request

65894-41-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

65894-41-9 Usage

Uses

Used in Pharmaceutical Industry:
Daturabietatriene is used as a research compound for understanding its interaction with muscarinic acetylcholine receptors. This knowledge aids in the development of drugs targeting these receptors for various therapeutic applications, such as treating Alzheimer's disease, schizophrenia, and other neurological disorders.
Used in Toxicological Research:
Daturabietatriene serves as a valuable tool in toxicological research to study the effects of plant toxins on the human body. This research helps in developing antidotes and treatments for poisoning caused by ingestion of Datura stramonium or other plants containing similar alkaloids.
Used in Forensic Science:
Daturabietatriene is utilized in forensic science for the detection and analysis of toxic plant substances in cases of poisoning or drug-related crimes. Its identification in biological samples can provide crucial evidence in legal investigations.
Used in Ethnobotanical Studies:
Daturabietatriene is employed in ethnobotanical studies to explore the traditional uses of Datura stramonium and other similar plants in various cultures. Understanding the historical and cultural context of these plants can provide insights into their potential medicinal properties and risks associated with their use.

Check Digit Verification of cas no

The CAS Registry Mumber 65894-41-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,8,9 and 4 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 65894-41:
(7*6)+(6*5)+(5*8)+(4*9)+(3*4)+(2*4)+(1*1)=169
169 % 10 = 9
So 65894-41-9 is a valid CAS Registry Number.

65894-41-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name Abieta-8,11,13-triene-15,18-diol

1.2 Other means of identification

Product number -
Other names 8,11,13-abietatriene-15,18-diol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:65894-41-9 SDS

65894-41-9Downstream Products

65894-41-9Relevant academic research and scientific papers

Design and synthesis of tricyclic terpenoid derivatives as novel PTP1B inhibitors with improved pharmacological property and in vivo antihyperglycaemic efficacy

Chen, Feng,Chen, Jiabao,Gao, Cheng,Li, Junyan,Liu, Siyan,Qian, Shan,Wang, Zhouyu,Yang, Lingling,Zhang, Yuanyuan

, p. 152 - 164 (2019/11/25)

Overexpression of protein tyrosine phosphatase 1B (PTP1B) induces insulin resistance in various basic and clinical research. In our previous work, a synthetic oleanolic acid (OA) derivative C10a with PTP1B inhibitory activity has been reported. However, C10a has some pharmacological defects and cytotoxicity. Herein, a structure-based drug design approach was used based on the structure of C10a to elaborate the smaller tricyclic core. A series of tricyclic derivatives were synthesised and the compounds 15, 28 and 34 exhibited the most PTP1B enzymatic inhibitory potency. In the insulin-resistant human hepatoma HepG2 cells, compound 25 with the moderate PTP1B inhibition and preferable pharmaceutical properties can significantly increase insulin-stimulated glucose uptake and showed the insulin resistance ameliorating effect. Moreover, 25 showed the improved in vivo antihyperglycaemic potential in the nicotinamide–streptozotocin-induced T2D. Our study demonstrated that these tricyclic derivatives with improved molecular architectures and antihyperglycaemic activity could be developed in the treatment of T2D.

Preparation method of 15-hydroxyl dehydrogenated abietane and intermediate of 15-hydroxyl dehydrogenated abietane

-

, (2017/08/29)

The invention discloses a preparation method of 15-hydroxyl dehydrogenated abietane and an intermediate of 15-hydroxyl dehydrogenated abietane. The preparation method comprises the following steps: converting a compound 1 into a compound 5, and converting the compound 5 into a compound 8. According to the method for preparing the compound 8, the problem that a product cannot be separated out of a glacial acetic acid solution because reaction impurities are remarkably increased when the feeding quantity is increased at the hydrogen bromide addition step in the existing synthesis route is solved through continuous screening of a process route. Furthermore, the method provided by the invention is high in yield at each step, easy to amplify and suitable for industrialized large-scale production. (The formula is as shown in the description.).

8. 11, 13 - Lohans Pinaceae - 13 - ol and intermediate preparation method (by machine translation)

-

, (2017/08/30)

The present invention discloses a process for preparing compound 9 shown 8, 11, 13 - Lohans Pinaceae - 13 - alcohol, or its pharmaceutically acceptable salt, or its solvate of the method, the method comprises the following steps: h, in the presence of oxidizing agent and acid, in order to compound 8 as raw material preparation to obtain compound 9; wherein oxidizing agent selected from hydrogen peroxide or over-tertiary butyl alcohol, acid selected from H2 SO4 , Toluenesulfonates. Process for making a compound of the present invention 9 of the method, the method is simple, high yield, easy to enlarge, and is suitable for industrial large-scale production. (by machine translation)

New route to 15-hydroxydehydroabietic acid derivatives: Application to the first synthesis of some bioactive abietane and nor-abietane type terpenoids

Alvarez-Manzaneda,Chahboun,Guardia,Lachkar,Dahdouh,Lara,Messouri

, p. 2577 - 2580 (2007/10/03)

A new route to 15-hydroxydehydroabietic acid derivatives from abietic acid (11), via abieta-8,13(15)-dien-18-oic acid (12), is reported. Utilizing this, the first synthesis of bioactive terpenes 3, 6, 9 and 10, as well as natural diol 4 and lactones 7-8 was achieved.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 65894-41-9